People taking GLP-1 weight-loss medications such as semaglutide and liraglutide ended up moving less in their daily lives, not more, according to a new analysis of Fitbit data from 753 participants in ...

Dana Farber Cancer Institute has partnered with Fitbit to launch a two-year randomized study that will investigate the impact of weight loss on breast cancer recurrence. The study, called the Breast ...

Adults who started taking GLP-1 receptor agonist drugs such as semaglutide logged fewer daily steps and less time exercising within months of beginning treatment, according to an analysis of ...

Weight Watchers announced that its app will now sync with activity trackers Jawbone and Fitbit so that users of the diet and food logging program can see how their fitness data correlates with their ...

The first time I realized my weight was a problem was when I was 8 years old. I overheard my doctor tell my mom that I was tipping the scale at over 100 pounds, and that she needed to start thinking ...

FITNESS TRACKERS HAVE become more sophisticated than ever, but they’re also getting a bit complicated. There are more sensors, more notifications, more monthly payments, and more data to make sense of ...